(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLYRASEPT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLYRASEPT

ST13

US500000098324411

Class

5

Filing

98324411

Registration

8274914

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

05/26/2026

Trademark type

Word

Nice classes

5

Filing date

12/20/2023

Registration date

05/26/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/26/2026

Last transaction

05/26/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/02/2026

First use in commerce

02/02/2026

Drawing code

4

Owner type

03

Owner location

Westminster, CA, US

Examiner

LINCOSKI JR, JOHN T

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Clyra Medical Technologies, Inc.

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical products with antimicrobial and disinfectant propertiespreparations for treatingretardingpreventing bacteria which cause diseases and infections topically and orally

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/26/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/04/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/04/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/02/2026

IUAF

USE AMENDMENT FILED

04/24/2026

EISU

TEAS STATEMENT OF USE RECEIVED

04/24/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/26/2025

EX2G

SOU EXTENSION 2 GRANTED

09/25/2025

EXT2

SOU EXTENSION 2 FILED

09/25/2025

EEXT

SOU TEAS EXTENSION RECEIVED

09/25/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/15/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/15/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/30/2025

EEXT

SOU TEAS EXTENSION RECEIVED

04/29/2025

EX1G

SOU EXTENSION 1 GRANTED

04/29/2025

EXT1

SOU EXTENSION 1 FILED

04/29/2025

DOCK

ASSIGNED TO EXAMINER

04/01/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/29/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/03/2024

PUBO

PUBLISHED FOR OPPOSITION

09/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/14/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/26/2024

DOCK

ASSIGNED TO EXAMINER

07/19/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/01/2024

NWAP

NEW APPLICATION ENTERED

12/20/2023

Continuous trademark protection

Get notified about every new filing that threatens CLYRASEPT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.